M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
ImmunoPrecise Antibodies appoints CORE IR to drive investor relations strategy
AI-driven biotherapeutics company ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) reported on Wednesday that it has engaged CORE IR, a strategic communications firm specialising in investor and public relations services, to enhance its investor engagement and communications strategy.
The...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search